As a payer, you are challenged to keep costs low while enabling appropriate care for your members. Eviti Connect is...
NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
According to a study published in The Commonweath Fund Issue Brief titled U.S. Health Care from a Global Perspective, 2022:...
HITRUST Certification validates NantHealth’s commitment to aligning with key regulations and protecting sensitive information MORRISVILLE, N.C. – March 21, 2023 — NantHealth,...
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a...
With many new emerging technologies in healthcare, we look at how these technologies impact patient-centric care. The Institute of Medicine defines patient-centric...
Quality health care should be accessible to everyone, but systemic inequities stand as intractable roadblocks for too many seeking access...
The designation demonstrates the highest level of commitment to quality healthcare Morrisville, NC – August 24, 2022 – NantHealth Inc. (NASDAQ: NH),...
Autoimmune diseases impact the daily lives of millions of people. Learn how you can expedite patient treatment and ensure quality...
NantHealth Senior Medical Director of Oncology, Dr. James Talcott, shared his insights on the use of treatment validation tech to...
Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
The complexity of cancer care continues to increase, and payers are under pressure to balance the dramatic rise in costs...